A vascular graft, also known as a vascular bypass, is a surgical treatment that bypasses a damaged artery by shifting blood from one area of normal blood flow to another. Different vascular grafts are available depending on the indication and raw materials used to suit the host tissue. Hemodialysis vascular access and endovascular aneurysm and thoracic aneurysm repair are both done with vascular grafts.

The vascular grafts market is expected to grow at a CAGR of 7.3 percent from USD 2.67 billion in 2017 to USD 3.80 billion in 2022. The high frequency of abdominal aneurysms, the growing geriatric population, and the rising prevalence of smoking and other risk factors that cause aneurysm are the primary drivers driving this market's expansion.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=179457001

"During the projected period, the polyester grafts segment will hold the greatest market share by raw material."
Because of the significant use of this material in vascular grafts and its extended lifespan, the polyester grafts segment is predicted to have the biggest market share. During the projection period, this segment is also expected to have the greatest CAGR.

"By indication, the endovascular aneurysm repair sector is expected to grow at the fastest rate and maintain the largest market share."
The expanding adoption of endovascular aneurysm repair surgical techniques, increasing preference for minimally invasive surgical procedures over open surgeries, and the growing geriatric population are all driving this segment's rise.

"Hospitals are predicted to increase at the fastest CAGR among end-users throughout the forecast period."
During the anticipated period, the hospitals category is expected to increase at the fastest CAGR. The strong growth of this segment can be attributable to reasons such as an increase in the number of minimally invasive surgical procedures performed in hospitals and cardiac centres, as well as attractive reimbursement scenarios in most industrialised nations.

"During the projected period, APAC will lead the worldwide vascular grafts market."
The increased prevalence of CKD, healthcare reforms, government initiatives and investments, and rapid growth in the senior population are all contributing to the Asia Pacific market's expanding growth. In addition, emerging markets such as Australia, Singapore, Japan, and China provide various potential prospects for vascular grafts market players because to an ageing population and an increase in end-stage renal disease.

Request Sample:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=179457001


Key Market Players
Medtronic (Ireland), B. Braun (Germany), Endologix (US), Terumo (Japan), C. R. Bard (US)